J. Cornillie, T. van Cann, A. Wozniak, D. Hompes i inni. Biology and management of clear cell sarcoma: state of the art and future perspectives. „Expert Rev Anticancer Ther”. 16 (8), s. 839-845, 2016. DOI: 10.1080/14737140.2016.1197122. PMID: 27253849.
SS. Malchau, J. Hayden, F. Hornicek, H. J. Mankin. Clear cell sarcoma of soft tissues. „J Surg Oncol”. 95 (6), s. 519-522, 2007. DOI: 10.1002/jso.20730. PMID: 17192915.
D. C. Dim, L. D. Cooley, R. N. Miranda. Clear cell sarcoma of tendons and aponeuroses: a review. „Arch Pathol Lab Med”. 131 (1), s. 152-156, 2007. DOI: [152:CCSOTA2.0.CO;2 10.1043/1543-2165(2007)131[152:CCSOTA]2.0.CO;2]. PMID: 17227118.
R. L. Jones, A. Constantinidou, K. Thway, S. Ashley i inni. Chemotherapy in clear cell sarcoma. „Med Oncol”. 28 (3), s. 859-863, 2011. DOI: 10.1007/s12032-010-9502-7. PMID: 20390470.
O. Hocar, A. Le Cesne, S. Berissi, P. Terrier i inni. Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 52 cases. „Dermatol Res Pract”. 2012, 2012. DOI: 10.1155/2012/984096. PMID: 22693489.
G. Bianchi, C. Charoenlap, S. Cocchi, N. Rani i inni. Clear cell sarcoma of soft tissue: a retrospective review and analysis of 31 cases treated at Istituto Ortopedico Rizzoli. „Eur J Surg Oncol”. 40 (5), s. 505-510, 2014. DOI: 10.1016/j.ejso.2014.01.016. PMID: 24560887.
W. L. Wang, E. Mayordomo, W. Zhang, V. S. Hernandez i inni. Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts). „Mod Pathol”. 22 (9), s. 1201-1209, 2009. DOI: 10.1038/modpathol.2009.85. PMID: 19561568.
K. Thway, C. Fisher. Tumors with EWSR1-CREB1 and EWSR1-ATF1 fusions: the current status. „Am J Surg Pathol”. 36 (7), 2012. DOI: 10.1097/PAS.0b013e31825485c5. PMID: 22510762.
I. J. Davis, J. J. Kim, F. Ozsolak, H. R. Widlund i inni. Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers. „Cancer Cell”. 9 (6), s. 473-484, 2006. DOI: 10.1016/j.ccr.2006.04.021. PMID: 16766266.
K. M. Straessler, K. B. Jones, H. Hu, H. Jin i inni. Modeling clear cell sarcomagenesis in the mouse: cell of origin differentiation state impacts tumor characteristics. „Cancer Cell”. 23 (2), s. 215-227, 2013. DOI: 10.1016/j.ccr.2012.12.019. PMID: 23410975.
W. Xiao, A. B. Mohseny, P. C. Hogendoorn, A. M. Cleton-Jansen. Mesenchymal stem cell transformation and sarcoma genesis. „Clin Sarcoma Res”. 3 (1), s. 10, 2013. DOI: 10.1186/2045-3329-3-10. PMID: 23880362.
M. A. Clark, M. B. Johnson, K. Thway, C. Fisher i inni. Clear cell sarcoma (melanoma of soft parts): The Royal Marsden Hospital experience. „Eur J Surg Oncol”. 34 (7), s. 800-804, 2008. DOI: 10.1016/j.ejso.2007.10.006. PMID: 18042498.
A. Ferrari, M. Casanova, G. Bisogno, A. Mattke i inni. Clear cell sarcoma of tendons and aponeuroses in pediatric patients: a report from the Italian and German Soft Tissue Sarcoma Cooperative Group. „Cancer”. 94 (12), s. 3269-3276, 2002. DOI: 10.1002/cncr.10597. PMID: 12115360.
T. Negri, S. Brich, E. Conca, F. Bozzi i inni. Receptor tyrosine kinase pathway analysis sheds light on similarities between clear-cell sarcoma and metastatic melanoma. „Genes Chromosomes Cancer”. 51 (2), s. 111-126, 2012. DOI: 10.1002/gcc.20933. PMID: 22045652.
S. Stacchiotti, F. Grosso, T. Negri, E. Palassini i inni. Tumor response to sunitinib malate observed in clear-cell sarcoma. „Ann Oncol”. 21 (5), s. 1130-1131, 2010. DOI: 10.1093/annonc/mdp611. PMID: 20093352.
O. Mir, P. Boudou-Rouquette, F. Larousserie, A. Babinet i inni. Objective response to sorafenib in advanced clear-cell sarcoma. „Ann Oncol”. 23 (3), s. 807-809, 2012. DOI: 10.1093/annonc/mds005. PMID: 22274882.
M. Tazzari, E. Palassini, B. Vergani, A. Villa i inni. Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report. „BMC Cancer”. 15, s. 58, 2015. DOI: 10.1186/s12885-015-1044-0. PMID: 25880253.
I. J. Davis, A. W. McFadden, Y. Zhang, A. Coxon i inni. Identification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcoma. „Cancer Res”. 70 (2), s. 639-645, 2010. DOI: 10.1158/0008-5472.CAN-09-1121. PMID: 20068147.
A. J. Wagner, J. M. Goldberg, S. G. Dubois, E. Choy i inni. Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trial. „Cancer”. 118 (23), s. 5894-5902, 2012. DOI: 10.1002/cncr.27582. PMID: 22605650.
D. G. Blazer, A. J. Lazar, Y. Xing, R. L. Askew i inni. Clinical outcomes of molecularly confirmed clear cell sarcoma from a single institution and in comparison with data from the Surveillance, Epidemiology, and End Results registry. „Cancer”. 115 (13), s. 2971-2979, 2009. DOI: 10.1002/cncr.24322. PMID: 19402173.
J. M. Meis-Kindblom, F. Enzinger. Clear cell sarcoma of tendons and aponeuroses: a historical perspective and tribute to the man behind the entity. „Adv Anat Pathol”. 13 (6), s. 286-292, 2006. DOI: 10.1097/01.pap.0000213052.92435.1f. PMID: 17075294.
J. Cornillie, T. van Cann, A. Wozniak, D. Hompes i inni. Biology and management of clear cell sarcoma: state of the art and future perspectives. „Expert Rev Anticancer Ther”. 16 (8), s. 839-845, 2016. DOI: 10.1080/14737140.2016.1197122. PMID: 27253849.
A. Mavrogenis, G. Bianchi, N. Stavropoulos, P. Papagelopoulos i inni. Clinicopathological features, diagnosis and treatment of clear cell sarcoma/melanoma of soft parts. „Hippokratia”. 17 (4), s. 298-302, 2013. PMID: 25031505.
SS. Malchau, J. Hayden, F. Hornicek, H. J. Mankin. Clear cell sarcoma of soft tissues. „J Surg Oncol”. 95 (6), s. 519-522, 2007. DOI: 10.1002/jso.20730. PMID: 17192915.
I. A. Jacobs, C. K. Chang, G. Guzman, G. I. Salti. Clear cell sarcoma: an institutional review. „Am Surg”. 70 (4), s. 300-303, 2004. PMID: 15098780.
D. C. Dim, L. D. Cooley, R. N. Miranda. Clear cell sarcoma of tendons and aponeuroses: a review. „Arch Pathol Lab Med”. 131 (1), s. 152-156, 2007. DOI: [152:CCSOTA2.0.CO;2 10.1043/1543-2165(2007)131[152:CCSOTA]2.0.CO;2]. PMID: 17227118.
R. L. Jones, A. Constantinidou, K. Thway, S. Ashley i inni. Chemotherapy in clear cell sarcoma. „Med Oncol”. 28 (3), s. 859-863, 2011. DOI: 10.1007/s12032-010-9502-7. PMID: 20390470.
O. Hocar, A. Le Cesne, S. Berissi, P. Terrier i inni. Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 52 cases. „Dermatol Res Pract”. 2012, 2012. DOI: 10.1155/2012/984096. PMID: 22693489.
G. Bianchi, C. Charoenlap, S. Cocchi, N. Rani i inni. Clear cell sarcoma of soft tissue: a retrospective review and analysis of 31 cases treated at Istituto Ortopedico Rizzoli. „Eur J Surg Oncol”. 40 (5), s. 505-510, 2014. DOI: 10.1016/j.ejso.2014.01.016. PMID: 24560887.
W. Deenik, W. J. Mooi, E. J. Rutgers, J. L. Peterse i inni. Clear cell sarcoma (malignant melanoma) of soft parts: A clinicopathologic study of 30 cases. „Cancer”. 86 (6), s. 969-975, 1999. PMID: 10491522.
W. L. Wang, E. Mayordomo, W. Zhang, V. S. Hernandez i inni. Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts). „Mod Pathol”. 22 (9), s. 1201-1209, 2009. DOI: 10.1038/modpathol.2009.85. PMID: 19561568.
K. Thway, C. Fisher. Tumors with EWSR1-CREB1 and EWSR1-ATF1 fusions: the current status. „Am J Surg Pathol”. 36 (7), 2012. DOI: 10.1097/PAS.0b013e31825485c5. PMID: 22510762.
I. J. Davis, J. J. Kim, F. Ozsolak, H. R. Widlund i inni. Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers. „Cancer Cell”. 9 (6), s. 473-484, 2006. DOI: 10.1016/j.ccr.2006.04.021. PMID: 16766266.
K. M. Straessler, K. B. Jones, H. Hu, H. Jin i inni. Modeling clear cell sarcomagenesis in the mouse: cell of origin differentiation state impacts tumor characteristics. „Cancer Cell”. 23 (2), s. 215-227, 2013. DOI: 10.1016/j.ccr.2012.12.019. PMID: 23410975.
W. Xiao, A. B. Mohseny, P. C. Hogendoorn, A. M. Cleton-Jansen. Mesenchymal stem cell transformation and sarcoma genesis. „Clin Sarcoma Res”. 3 (1), s. 10, 2013. DOI: 10.1186/2045-3329-3-10. PMID: 23880362.
D. R. Kuiper, H. J. Hoekstra, R. P. Veth, T. Wobbes. The management of clear cell sarcoma. „Eur J Surg Oncol”. 29 (7), s. 568-570, 2003. PMID: 12943620.
M. A. Clark, M. B. Johnson, K. Thway, C. Fisher i inni. Clear cell sarcoma (melanoma of soft parts): The Royal Marsden Hospital experience. „Eur J Surg Oncol”. 34 (7), s. 800-804, 2008. DOI: 10.1016/j.ejso.2007.10.006. PMID: 18042498.
J. W. Finley, B. Hanypsiak, B. McGrath, W. Kraybill i inni. Clear cell sarcoma: the Roswell Park experience. „J Surg Oncol”. 77 (1), s. 16-20, 2001. PMID: 11344475.
A. Ferrari, M. Casanova, G. Bisogno, A. Mattke i inni. Clear cell sarcoma of tendons and aponeuroses in pediatric patients: a report from the Italian and German Soft Tissue Sarcoma Cooperative Group. „Cancer”. 94 (12), s. 3269-3276, 2002. DOI: 10.1002/cncr.10597. PMID: 12115360.
T. Negri, S. Brich, E. Conca, F. Bozzi i inni. Receptor tyrosine kinase pathway analysis sheds light on similarities between clear-cell sarcoma and metastatic melanoma. „Genes Chromosomes Cancer”. 51 (2), s. 111-126, 2012. DOI: 10.1002/gcc.20933. PMID: 22045652.
S. Stacchiotti, F. Grosso, T. Negri, E. Palassini i inni. Tumor response to sunitinib malate observed in clear-cell sarcoma. „Ann Oncol”. 21 (5), s. 1130-1131, 2010. DOI: 10.1093/annonc/mdp611. PMID: 20093352.
O. Mir, P. Boudou-Rouquette, F. Larousserie, A. Babinet i inni. Objective response to sorafenib in advanced clear-cell sarcoma. „Ann Oncol”. 23 (3), s. 807-809, 2012. DOI: 10.1093/annonc/mds005. PMID: 22274882.
M. Tazzari, E. Palassini, B. Vergani, A. Villa i inni. Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report. „BMC Cancer”. 15, s. 58, 2015. DOI: 10.1186/s12885-015-1044-0. PMID: 25880253.
I. J. Davis, A. W. McFadden, Y. Zhang, A. Coxon i inni. Identification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcoma. „Cancer Res”. 70 (2), s. 639-645, 2010. DOI: 10.1158/0008-5472.CAN-09-1121. PMID: 20068147.
A. J. Wagner, J. M. Goldberg, S. G. Dubois, E. Choy i inni. Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trial. „Cancer”. 118 (23), s. 5894-5902, 2012. DOI: 10.1002/cncr.27582. PMID: 22605650.
D. G. Blazer, A. J. Lazar, Y. Xing, R. L. Askew i inni. Clinical outcomes of molecularly confirmed clear cell sarcoma from a single institution and in comparison with data from the Surveillance, Epidemiology, and End Results registry. „Cancer”. 115 (13), s. 2971-2979, 2009. DOI: 10.1002/cncr.24322. PMID: 19402173.
J. M. Meis-Kindblom, F. Enzinger. Clear cell sarcoma of tendons and aponeuroses: a historical perspective and tribute to the man behind the entity. „Adv Anat Pathol”. 13 (6), s. 286-292, 2006. DOI: 10.1097/01.pap.0000213052.92435.1f. PMID: 17075294.